nodes	percent_of_prediction	percent_of_DWPC	metapath
Valganciclovir—SLC6A14—Imatinib Resistance in Chronic Myeloid Leukemia—SLC4A10—epilepsy syndrome	0.00841	0.0331	CbGpPWpGaD
Valganciclovir—SLC6A14—Na+/Cl- dependent neurotransmitter transporters—SLC6A1—epilepsy syndrome	0.00726	0.0286	CbGpPWpGaD
Valganciclovir—SLC6A14—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC12A5—epilepsy syndrome	0.00541	0.0213	CbGpPWpGaD
Valganciclovir—SLC6A14—Amino acid and oligopeptide SLC transporters—SLC1A1—epilepsy syndrome	0.00528	0.0208	CbGpPWpGaD
Valganciclovir—SLC6A14—Amine compound SLC transporters—SLC6A1—epilepsy syndrome	0.00504	0.0198	CbGpPWpGaD
Valganciclovir—SLC6A14—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC4A10—epilepsy syndrome	0.00495	0.0195	CbGpPWpGaD
Valganciclovir—SLC6A14—Amino acid and oligopeptide SLC transporters—SLC17A7—epilepsy syndrome	0.00483	0.019	CbGpPWpGaD
Valganciclovir—SLC6A14—Amino acid and oligopeptide SLC transporters—SLC1A2—epilepsy syndrome	0.00449	0.0177	CbGpPWpGaD
Valganciclovir—SLC6A14—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC8A2—epilepsy syndrome	0.0041	0.0162	CbGpPWpGaD
Valganciclovir—SLC6A14—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC9A6—epilepsy syndrome	0.0041	0.0162	CbGpPWpGaD
Valganciclovir—SLC6A14—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC8A3—epilepsy syndrome	0.00391	0.0154	CbGpPWpGaD
Valganciclovir—SLC6A14—Amino acid and oligopeptide SLC transporters—SLC1A3—epilepsy syndrome	0.00382	0.015	CbGpPWpGaD
Valganciclovir—SLC6A14—Imatinib Resistance in Chronic Myeloid Leukemia—ABCG2—epilepsy syndrome	0.00311	0.0123	CbGpPWpGaD
Valganciclovir—SLC6A14—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC12A2—epilepsy syndrome	0.00311	0.0122	CbGpPWpGaD
Valganciclovir—SLC6A14—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC1A1—epilepsy syndrome	0.00311	0.0122	CbGpPWpGaD
Valganciclovir—SLC6A14—NRF2 pathway—SLC6A8—epilepsy syndrome	0.00291	0.0115	CbGpPWpGaD
Valganciclovir—SLC6A14—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC17A7—epilepsy syndrome	0.00284	0.0112	CbGpPWpGaD
Valganciclovir—SLC6A14—Imatinib Resistance in Chronic Myeloid Leukemia—EPO—epilepsy syndrome	0.00267	0.0105	CbGpPWpGaD
Valganciclovir—SLC6A14—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC1A2—epilepsy syndrome	0.00264	0.0104	CbGpPWpGaD
Valganciclovir—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC12A5—epilepsy syndrome	0.00256	0.0101	CbGpPWpGaD
Valganciclovir—SLC15A2—Amino acid and oligopeptide SLC transporters—SLC1A1—epilepsy syndrome	0.0025	0.00984	CbGpPWpGaD
Valganciclovir—SLC6A14—SLC-mediated transmembrane transport—SLC12A5—epilepsy syndrome	0.00242	0.00953	CbGpPWpGaD
Valganciclovir—SLC6A14—SLC-mediated transmembrane transport—SLC35A3—epilepsy syndrome	0.00242	0.00953	CbGpPWpGaD
Valganciclovir—SLC6A14—SLC-mediated transmembrane transport—SLC35A2—epilepsy syndrome	0.00242	0.00953	CbGpPWpGaD
Valganciclovir—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC12A5—epilepsy syndrome	0.00238	0.00936	CbGpPWpGaD
Valganciclovir—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC4A10—epilepsy syndrome	0.00234	0.00922	CbGpPWpGaD
Valganciclovir—SLC6A14—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC8A1—epilepsy syndrome	0.00233	0.00917	CbGpPWpGaD
Valganciclovir—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC1A1—epilepsy syndrome	0.00232	0.00913	CbGpPWpGaD
Valganciclovir—SLC15A2—Amino acid and oligopeptide SLC transporters—SLC17A7—epilepsy syndrome	0.00228	0.009	CbGpPWpGaD
Valganciclovir—SLC6A14—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC1A3—epilepsy syndrome	0.00225	0.00885	CbGpPWpGaD
Valganciclovir—SLC6A14—SLC-mediated transmembrane transport—SLC4A10—epilepsy syndrome	0.00221	0.00871	CbGpPWpGaD
Valganciclovir—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC4A10—epilepsy syndrome	0.00217	0.00856	CbGpPWpGaD
Valganciclovir—SLC15A2—Amino acid and oligopeptide SLC transporters—SLC1A2—epilepsy syndrome	0.00212	0.00836	CbGpPWpGaD
Valganciclovir—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC17A7—epilepsy syndrome	0.00212	0.00835	CbGpPWpGaD
Valganciclovir—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC1A2—epilepsy syndrome	0.00197	0.00776	CbGpPWpGaD
Valganciclovir—SLC6A14—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—epilepsy syndrome	0.00197	0.00776	CbGpPWpGaD
Valganciclovir—SLC6A14—Imatinib Resistance in Chronic Myeloid Leukemia—ABCB1—epilepsy syndrome	0.00194	0.00765	CbGpPWpGaD
Valganciclovir—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC8A2—epilepsy syndrome	0.00194	0.00764	CbGpPWpGaD
Valganciclovir—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC9A6—epilepsy syndrome	0.00194	0.00764	CbGpPWpGaD
Valganciclovir—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC8A3—epilepsy syndrome	0.00185	0.00729	CbGpPWpGaD
Valganciclovir—SLC6A14—SLC-mediated transmembrane transport—SLCO1A2—epilepsy syndrome	0.00183	0.00722	CbGpPWpGaD
Valganciclovir—SLC6A14—SLC-mediated transmembrane transport—SLC8A2—epilepsy syndrome	0.00183	0.00722	CbGpPWpGaD
Valganciclovir—SLC6A14—SLC-mediated transmembrane transport—SLC9A6—epilepsy syndrome	0.00183	0.00722	CbGpPWpGaD
Valganciclovir—SLC6A14—NRF2 pathway—TXNRD1—epilepsy syndrome	0.00182	0.00715	CbGpPWpGaD
Valganciclovir—SLC15A2—Amino acid and oligopeptide SLC transporters—SLC1A3—epilepsy syndrome	0.00181	0.00711	CbGpPWpGaD
Valganciclovir—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC8A2—epilepsy syndrome	0.0018	0.00709	CbGpPWpGaD
Valganciclovir—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC9A6—epilepsy syndrome	0.0018	0.00709	CbGpPWpGaD
Valganciclovir—SLC6A14—SLC-mediated transmembrane transport—SLC8A3—epilepsy syndrome	0.00175	0.00689	CbGpPWpGaD
Valganciclovir—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC8A3—epilepsy syndrome	0.00172	0.00677	CbGpPWpGaD
Valganciclovir—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC1A3—epilepsy syndrome	0.00168	0.0066	CbGpPWpGaD
Valganciclovir—SLC6A14—NRF2 pathway—ABCC2—epilepsy syndrome	0.00153	0.00602	CbGpPWpGaD
Valganciclovir—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC1A1—epilepsy syndrome	0.00147	0.00579	CbGpPWpGaD
Valganciclovir—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC12A2—epilepsy syndrome	0.00147	0.00579	CbGpPWpGaD
Valganciclovir—SLC6A14—SLC-mediated transmembrane transport—APOD—epilepsy syndrome	0.00143	0.00562	CbGpPWpGaD
Valganciclovir—SLC6A14—NRF2 pathway—SLC6A1—epilepsy syndrome	0.00142	0.0056	CbGpPWpGaD
Valganciclovir—SLC6A14—SLC-mediated transmembrane transport—SLC1A1—epilepsy syndrome	0.00139	0.00547	CbGpPWpGaD
Valganciclovir—SLC6A14—SLC-mediated transmembrane transport—SLC12A2—epilepsy syndrome	0.00139	0.00547	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—CLCN2—epilepsy syndrome	0.00138	0.00543	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—CLCN6—epilepsy syndrome	0.00138	0.00543	CbGpPWpGaD
Valganciclovir—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC1A1—epilepsy syndrome	0.00137	0.00538	CbGpPWpGaD
Valganciclovir—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC12A2—epilepsy syndrome	0.00137	0.00538	CbGpPWpGaD
Valganciclovir—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC17A7—epilepsy syndrome	0.00135	0.0053	CbGpPWpGaD
Valganciclovir—SLC6A14—SLC-mediated transmembrane transport—SLC17A7—epilepsy syndrome	0.00127	0.005	CbGpPWpGaD
Valganciclovir—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC1A2—epilepsy syndrome	0.00125	0.00492	CbGpPWpGaD
Valganciclovir—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC17A7—epilepsy syndrome	0.00125	0.00492	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—SLC35A3—epilepsy syndrome	0.00123	0.00484	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—SLC35A2—epilepsy syndrome	0.00123	0.00484	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—SLC12A5—epilepsy syndrome	0.00123	0.00484	CbGpPWpGaD
Valganciclovir—SLC6A14—SLC-mediated transmembrane transport—SLC1A2—epilepsy syndrome	0.00118	0.00465	CbGpPWpGaD
Valganciclovir—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC1A2—epilepsy syndrome	0.00116	0.00457	CbGpPWpGaD
Valganciclovir—SLC15A2—SLC-mediated transmembrane transport—SLC35A3—epilepsy syndrome	0.00114	0.00451	CbGpPWpGaD
Valganciclovir—SLC15A2—SLC-mediated transmembrane transport—SLC35A2—epilepsy syndrome	0.00114	0.00451	CbGpPWpGaD
Valganciclovir—SLC15A2—SLC-mediated transmembrane transport—SLC12A5—epilepsy syndrome	0.00114	0.00451	CbGpPWpGaD
Valganciclovir—SLC6A14—NRF2 pathway—SLC6A4—epilepsy syndrome	0.00114	0.00447	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—SLC4A10—epilepsy syndrome	0.00112	0.00443	CbGpPWpGaD
Valganciclovir—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC8A1—epilepsy syndrome	0.0011	0.00434	CbGpPWpGaD
Valganciclovir—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC1A3—epilepsy syndrome	0.00106	0.00419	CbGpPWpGaD
Valganciclovir—SLC15A1—SLC-mediated transmembrane transport—SLC35A3—epilepsy syndrome	0.00106	0.00418	CbGpPWpGaD
Valganciclovir—SLC15A1—SLC-mediated transmembrane transport—SLC35A2—epilepsy syndrome	0.00106	0.00418	CbGpPWpGaD
Valganciclovir—SLC15A1—SLC-mediated transmembrane transport—SLC12A5—epilepsy syndrome	0.00106	0.00418	CbGpPWpGaD
Valganciclovir—SLC15A2—SLC-mediated transmembrane transport—SLC4A10—epilepsy syndrome	0.00105	0.00412	CbGpPWpGaD
Valganciclovir—SLC6A14—SLC-mediated transmembrane transport—SLC8A1—epilepsy syndrome	0.00104	0.0041	CbGpPWpGaD
Valganciclovir—SLC6A14—NRF2 pathway—SLC2A1—epilepsy syndrome	0.00103	0.00405	CbGpPWpGaD
Valganciclovir—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC8A1—epilepsy syndrome	0.00102	0.00402	CbGpPWpGaD
Valganciclovir—SLC6A14—SLC-mediated transmembrane transport—SLC1A3—epilepsy syndrome	0.001	0.00396	CbGpPWpGaD
Valganciclovir—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC1A3—epilepsy syndrome	0.000987	0.00389	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—COX3—epilepsy syndrome	0.000983	0.00387	CbGpPWpGaD
Valganciclovir—SLC15A1—SLC-mediated transmembrane transport—SLC4A10—epilepsy syndrome	0.000971	0.00383	CbGpPWpGaD
Valganciclovir—SLC6A14—NRF2 pathway—HBEGF—epilepsy syndrome	0.000966	0.0038	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—SLC8A2—epilepsy syndrome	0.000932	0.00367	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—SLCO1A2—epilepsy syndrome	0.000932	0.00367	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—SLC9A6—epilepsy syndrome	0.000932	0.00367	CbGpPWpGaD
Valganciclovir—SLC6A14—SLC-mediated transmembrane transport—SLC6A1—epilepsy syndrome	0.000896	0.00353	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—SLC8A3—epilepsy syndrome	0.000889	0.0035	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—GABRG2—epilepsy syndrome	0.000889	0.0035	CbGpPWpGaD
Valganciclovir—SLC15A2—SLC-mediated transmembrane transport—SLC8A2—epilepsy syndrome	0.000867	0.00342	CbGpPWpGaD
Valganciclovir—SLC15A2—SLC-mediated transmembrane transport—SLCO1A2—epilepsy syndrome	0.000867	0.00342	CbGpPWpGaD
Valganciclovir—SLC15A2—SLC-mediated transmembrane transport—SLC9A6—epilepsy syndrome	0.000867	0.00342	CbGpPWpGaD
Valganciclovir—SLC6A14—NRF2 pathway—HMOX1—epilepsy syndrome	0.000845	0.00333	CbGpPWpGaD
Valganciclovir—SLC15A2—SLC-mediated transmembrane transport—SLC8A3—epilepsy syndrome	0.000827	0.00326	CbGpPWpGaD
Valganciclovir—SLC15A1—SLC-mediated transmembrane transport—SLCO1A2—epilepsy syndrome	0.000805	0.00317	CbGpPWpGaD
Valganciclovir—SLC15A1—SLC-mediated transmembrane transport—SLC8A2—epilepsy syndrome	0.000805	0.00317	CbGpPWpGaD
Valganciclovir—SLC15A1—SLC-mediated transmembrane transport—SLC9A6—epilepsy syndrome	0.000805	0.00317	CbGpPWpGaD
Valganciclovir—SLC15A1—SLC-mediated transmembrane transport—SLC8A3—epilepsy syndrome	0.000768	0.00302	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—APOD—epilepsy syndrome	0.000725	0.00285	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—SLC1A1—epilepsy syndrome	0.000706	0.00278	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—SLC12A2—epilepsy syndrome	0.000706	0.00278	CbGpPWpGaD
Valganciclovir—SLC15A2—SLC-mediated transmembrane transport—APOD—epilepsy syndrome	0.000675	0.00266	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—GABRA5—epilepsy syndrome	0.000674	0.00265	CbGpPWpGaD
Valganciclovir—SLC15A2—SLC-mediated transmembrane transport—SLC12A2—epilepsy syndrome	0.000657	0.00259	CbGpPWpGaD
Valganciclovir—SLC15A2—SLC-mediated transmembrane transport—SLC1A1—epilepsy syndrome	0.000657	0.00259	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—CLCN2—epilepsy syndrome	0.000652	0.00257	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—CLCN6—epilepsy syndrome	0.000652	0.00257	CbGpPWpGaD
Valganciclovir—SLC6A14—SLC-mediated transmembrane transport—SLC2A1—epilepsy syndrome	0.000647	0.00255	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—ARHGEF9—epilepsy syndrome	0.000646	0.00254	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—GABRB3—epilepsy syndrome	0.000646	0.00254	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—GABRA1—epilepsy syndrome	0.000646	0.00254	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—SLC17A7—epilepsy syndrome	0.000646	0.00254	CbGpPWpGaD
Valganciclovir—SLC15A1—SLC-mediated transmembrane transport—APOD—epilepsy syndrome	0.000626	0.00246	CbGpPWpGaD
Valganciclovir—SLC15A1—SLC-mediated transmembrane transport—SLC1A1—epilepsy syndrome	0.00061	0.0024	CbGpPWpGaD
Valganciclovir—SLC15A1—SLC-mediated transmembrane transport—SLC12A2—epilepsy syndrome	0.00061	0.0024	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—CLCN2—epilepsy syndrome	0.000606	0.00238	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—CLCN6—epilepsy syndrome	0.000606	0.00238	CbGpPWpGaD
Valganciclovir—SLC15A2—SLC-mediated transmembrane transport—SLC17A7—epilepsy syndrome	0.000601	0.00237	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—SLC1A2—epilepsy syndrome	0.0006	0.00236	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—SLC35A3—epilepsy syndrome	0.000582	0.00229	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—SLC35A2—epilepsy syndrome	0.000582	0.00229	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—SLC12A5—epilepsy syndrome	0.000582	0.00229	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—GABRB2—epilepsy syndrome	0.000573	0.00226	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—AQP1—epilepsy syndrome	0.000565	0.00222	CbGpPWpGaD
Valganciclovir—SLC15A2—SLC-mediated transmembrane transport—SLC1A2—epilepsy syndrome	0.000559	0.0022	CbGpPWpGaD
Valganciclovir—SLC15A1—SLC-mediated transmembrane transport—SLC17A7—epilepsy syndrome	0.000558	0.0022	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—TRPV1—epilepsy syndrome	0.000549	0.00216	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—SLC12A5—epilepsy syndrome	0.00054	0.00213	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—SLC35A3—epilepsy syndrome	0.00054	0.00213	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—SLC35A2—epilepsy syndrome	0.00054	0.00213	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—SLC4A10—epilepsy syndrome	0.000532	0.00209	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—SLC8A1—epilepsy syndrome	0.000529	0.00208	CbGpPWpGaD
Valganciclovir—SLC6A14—SLC-mediated transmembrane transport—AVP—epilepsy syndrome	0.000528	0.00208	CbGpPWpGaD
Valganciclovir—SLC15A1—SLC-mediated transmembrane transport—SLC1A2—epilepsy syndrome	0.000519	0.00204	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—SLC1A3—epilepsy syndrome	0.000511	0.00201	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—AQP4—epilepsy syndrome	0.000511	0.00201	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—SLC4A10—epilepsy syndrome	0.000494	0.00194	CbGpPWpGaD
Valganciclovir—SLC15A2—SLC-mediated transmembrane transport—SLC8A1—epilepsy syndrome	0.000492	0.00194	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—ABCC2—epilepsy syndrome	0.00049	0.00193	CbGpPWpGaD
Valganciclovir—SLC15A2—SLC-mediated transmembrane transport—SLC1A3—epilepsy syndrome	0.000475	0.00187	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—COX3—epilepsy syndrome	0.000465	0.00183	CbGpPWpGaD
Valganciclovir—SLC15A1—SLC-mediated transmembrane transport—SLC8A1—epilepsy syndrome	0.000457	0.0018	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	0.000455	0.00179	CbGpPWpGaD
Valganciclovir—SLC15A1—SLC-mediated transmembrane transport—SLC1A3—epilepsy syndrome	0.000441	0.00174	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—SLCO1A2—epilepsy syndrome	0.000441	0.00174	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—SLC8A2—epilepsy syndrome	0.000441	0.00174	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—SLC9A6—epilepsy syndrome	0.000441	0.00174	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—COX3—epilepsy syndrome	0.000431	0.0017	CbGpPWpGaD
Valganciclovir—SLC15A2—SLC-mediated transmembrane transport—SLC6A1—epilepsy syndrome	0.000424	0.00167	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—SLC8A3—epilepsy syndrome	0.00042	0.00166	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—GABRG2—epilepsy syndrome	0.00042	0.00166	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	0.000416	0.00164	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—SLCO1A2—epilepsy syndrome	0.000409	0.00161	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—SLC8A2—epilepsy syndrome	0.000409	0.00161	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—SLC9A6—epilepsy syndrome	0.000409	0.00161	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	0.000406	0.0016	CbGpPWpGaD
Valganciclovir—SLC15A1—SLC-mediated transmembrane transport—SLC6A1—epilepsy syndrome	0.000393	0.00155	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—GABRG2—epilepsy syndrome	0.00039	0.00154	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—SLC8A3—epilepsy syndrome	0.00039	0.00154	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	0.000345	0.00136	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—APOD—epilepsy syndrome	0.000343	0.00135	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—SLC1A1—epilepsy syndrome	0.000334	0.00132	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—SLC12A2—epilepsy syndrome	0.000334	0.00132	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	0.000329	0.0013	CbGpPWpGaD
Valganciclovir—SLC6A14—SLC-mediated transmembrane transport—ALB—epilepsy syndrome	0.00032	0.00126	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—GABRA5—epilepsy syndrome	0.000319	0.00125	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—APOD—epilepsy syndrome	0.000318	0.00125	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—SLC1A1—epilepsy syndrome	0.00031	0.00122	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—SLC12A2—epilepsy syndrome	0.00031	0.00122	CbGpPWpGaD
Valganciclovir—SLC15A2—SLC-mediated transmembrane transport—SLC2A1—epilepsy syndrome	0.000306	0.00121	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—ARHGEF9—epilepsy syndrome	0.000305	0.0012	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—SLC17A7—epilepsy syndrome	0.000305	0.0012	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—GABRA1—epilepsy syndrome	0.000305	0.0012	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—GABRB3—epilepsy syndrome	0.000305	0.0012	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—GABRA5—epilepsy syndrome	0.000296	0.00116	CbGpPWpGaD
Valganciclovir—SLC15A1—SLC-mediated transmembrane transport—SLC2A1—epilepsy syndrome	0.000284	0.00112	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—SLC1A2—epilepsy syndrome	0.000284	0.00112	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—ARHGEF9—epilepsy syndrome	0.000284	0.00112	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—SLC17A7—epilepsy syndrome	0.000284	0.00112	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—GABRB3—epilepsy syndrome	0.000284	0.00112	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—GABRA1—epilepsy syndrome	0.000284	0.00112	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—GABRB2—epilepsy syndrome	0.000271	0.00107	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	0.000271	0.00107	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—AVP—epilepsy syndrome	0.000268	0.00106	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—AQP1—epilepsy syndrome	0.000267	0.00105	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—SLC1A2—epilepsy syndrome	0.000264	0.00104	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—TRPV1—epilepsy syndrome	0.00026	0.00102	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	0.00026	0.00102	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—GABRB2—epilepsy syndrome	0.000251	0.00099	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—SLC8A1—epilepsy syndrome	0.00025	0.000985	CbGpPWpGaD
Valganciclovir—SLC15A2—SLC-mediated transmembrane transport—AVP—epilepsy syndrome	0.00025	0.000983	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—AQP1—epilepsy syndrome	0.000248	0.000976	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—SLC1A3—epilepsy syndrome	0.000241	0.000951	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—AQP4—epilepsy syndrome	0.000241	0.000951	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—TRPV1—epilepsy syndrome	0.000241	0.000949	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—SLC8A1—epilepsy syndrome	0.000232	0.000914	CbGpPWpGaD
Valganciclovir—SLC15A1—SLC-mediated transmembrane transport—AVP—epilepsy syndrome	0.000232	0.000912	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—ABCC2—epilepsy syndrome	0.000232	0.000912	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—AQP4—epilepsy syndrome	0.000224	0.000882	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—SLC1A3—epilepsy syndrome	0.000224	0.000882	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	0.000215	0.000848	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—ABCC2—epilepsy syndrome	0.000215	0.000846	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	0.0002	0.000787	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	0.000197	0.000775	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	0.000192	0.000755	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	0.000183	0.000719	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	0.000178	0.000701	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	0.000163	0.000642	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—ALB—epilepsy syndrome	0.000162	0.00064	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	0.000156	0.000613	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	0.000151	0.000596	CbGpPWpGaD
Valganciclovir—Hyperhidrosis—Valproic Acid—epilepsy syndrome	0.000151	0.000203	CcSEcCtD
Valganciclovir—Cough—Pregabalin—epilepsy syndrome	0.000151	0.000203	CcSEcCtD
Valganciclovir—SLC15A2—SLC-mediated transmembrane transport—ALB—epilepsy syndrome	0.000151	0.000596	CbGpPWpGaD
Valganciclovir—Pruritus—Phenytoin—epilepsy syndrome	0.000151	0.000202	CcSEcCtD
Valganciclovir—Connective tissue disorder—Topiramate—epilepsy syndrome	0.000151	0.000202	CcSEcCtD
Valganciclovir—Nausea—Levetiracetam—epilepsy syndrome	0.000151	0.000202	CcSEcCtD
Valganciclovir—Dizziness—Felbamate—epilepsy syndrome	0.000151	0.000202	CcSEcCtD
Valganciclovir—Dermatitis—Vigabatrin—epilepsy syndrome	0.000151	0.000202	CcSEcCtD
Valganciclovir—Urethral disorder—Topiramate—epilepsy syndrome	0.000151	0.000202	CcSEcCtD
Valganciclovir—Pruritus—Oxcarbazepine—epilepsy syndrome	0.00015	0.000201	CcSEcCtD
Valganciclovir—Convulsion—Pregabalin—epilepsy syndrome	0.00015	0.000201	CcSEcCtD
Valganciclovir—Hypersensitivity—Carbamazepine—epilepsy syndrome	0.00015	0.000201	CcSEcCtD
Valganciclovir—Vision blurred—Gabapentin—epilepsy syndrome	0.00015	0.000201	CcSEcCtD
Valganciclovir—Headache—Vigabatrin—epilepsy syndrome	0.00015	0.000201	CcSEcCtD
Valganciclovir—Hypertension—Pregabalin—epilepsy syndrome	0.00015	0.000201	CcSEcCtD
Valganciclovir—Vomiting—Diazepam—epilepsy syndrome	0.00015	0.000201	CcSEcCtD
Valganciclovir—Anorexia—Valproic Acid—epilepsy syndrome	0.000149	0.0002	CcSEcCtD
Valganciclovir—Tremor—Gabapentin—epilepsy syndrome	0.000149	0.0002	CcSEcCtD
Valganciclovir—Dermatitis—Diazepam—epilepsy syndrome	0.000148	0.000199	CcSEcCtD
Valganciclovir—Visual impairment—Topiramate—epilepsy syndrome	0.000148	0.000198	CcSEcCtD
Valganciclovir—Arthralgia—Pregabalin—epilepsy syndrome	0.000148	0.000198	CcSEcCtD
Valganciclovir—Ill-defined disorder—Gabapentin—epilepsy syndrome	0.000148	0.000198	CcSEcCtD
Valganciclovir—Dizziness—Zonisamide—epilepsy syndrome	0.000147	0.000198	CcSEcCtD
Valganciclovir—Headache—Diazepam—epilepsy syndrome	0.000147	0.000198	CcSEcCtD
Valganciclovir—Anxiety—Pregabalin—epilepsy syndrome	0.000147	0.000197	CcSEcCtD
Valganciclovir—Diarrhoea—Clonazepam—epilepsy syndrome	0.000147	0.000197	CcSEcCtD
Valganciclovir—Anaemia—Gabapentin—epilepsy syndrome	0.000147	0.000197	CcSEcCtD
Valganciclovir—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	0.000147	0.000196	CcSEcCtD
Valganciclovir—Hypotension—Valproic Acid—epilepsy syndrome	0.000146	0.000196	CcSEcCtD
Valganciclovir—Asthenia—Carbamazepine—epilepsy syndrome	0.000146	0.000196	CcSEcCtD
Valganciclovir—Agitation—Gabapentin—epilepsy syndrome	0.000146	0.000196	CcSEcCtD
Valganciclovir—Diarrhoea—Phenytoin—epilepsy syndrome	0.000146	0.000196	CcSEcCtD
Valganciclovir—Discomfort—Pregabalin—epilepsy syndrome	0.000146	0.000195	CcSEcCtD
Valganciclovir—Nausea—Fosphenytoin—epilepsy syndrome	0.000146	0.000195	CcSEcCtD
Valganciclovir—Diarrhoea—Oxcarbazepine—epilepsy syndrome	0.000145	0.000195	CcSEcCtD
Valganciclovir—Hypersensitivity—Lamotrigine—epilepsy syndrome	0.000145	0.000195	CcSEcCtD
Valganciclovir—Vomiting—Felbamate—epilepsy syndrome	0.000145	0.000194	CcSEcCtD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	0.000144	0.000569	CbGpPWpGaD
Valganciclovir—Dry mouth—Pregabalin—epilepsy syndrome	0.000144	0.000193	CcSEcCtD
Valganciclovir—Pruritus—Carbamazepine—epilepsy syndrome	0.000144	0.000193	CcSEcCtD
Valganciclovir—Eye disorder—Topiramate—epilepsy syndrome	0.000144	0.000192	CcSEcCtD
Valganciclovir—Dermatitis—Felbamate—epilepsy syndrome	0.000144	0.000192	CcSEcCtD
Valganciclovir—Malaise—Gabapentin—epilepsy syndrome	0.000143	0.000192	CcSEcCtD
Valganciclovir—Tinnitus—Topiramate—epilepsy syndrome	0.000143	0.000192	CcSEcCtD
Valganciclovir—Vertigo—Gabapentin—epilepsy syndrome	0.000143	0.000191	CcSEcCtD
Valganciclovir—Headache—Felbamate—epilepsy syndrome	0.000143	0.000191	CcSEcCtD
Valganciclovir—Confusional state—Pregabalin—epilepsy syndrome	0.000143	0.000191	CcSEcCtD
Valganciclovir—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	0.000143	0.000191	CcSEcCtD
Valganciclovir—Cardiac disorder—Topiramate—epilepsy syndrome	0.000143	0.000191	CcSEcCtD
Valganciclovir—Leukopenia—Gabapentin—epilepsy syndrome	0.000142	0.000191	CcSEcCtD
Valganciclovir—Dizziness—Clonazepam—epilepsy syndrome	0.000142	0.000191	CcSEcCtD
Valganciclovir—Nausea—Vigabatrin—epilepsy syndrome	0.000142	0.00019	CcSEcCtD
Valganciclovir—Vomiting—Zonisamide—epilepsy syndrome	0.000142	0.00019	CcSEcCtD
Valganciclovir—Insomnia—Valproic Acid—epilepsy syndrome	0.000142	0.00019	CcSEcCtD
Valganciclovir—Oedema—Pregabalin—epilepsy syndrome	0.000141	0.00019	CcSEcCtD
Valganciclovir—Anaphylactic shock—Pregabalin—epilepsy syndrome	0.000141	0.00019	CcSEcCtD
Valganciclovir—Asthenia—Lamotrigine—epilepsy syndrome	0.000141	0.000189	CcSEcCtD
Valganciclovir—Dizziness—Phenytoin—epilepsy syndrome	0.000141	0.000189	CcSEcCtD
Valganciclovir—Infection—Pregabalin—epilepsy syndrome	0.000141	0.000188	CcSEcCtD
Valganciclovir—Paraesthesia—Valproic Acid—epilepsy syndrome	0.000141	0.000188	CcSEcCtD
Valganciclovir—Dermatitis—Zonisamide—epilepsy syndrome	0.00014	0.000188	CcSEcCtD
Valganciclovir—Dizziness—Oxcarbazepine—epilepsy syndrome	0.00014	0.000188	CcSEcCtD
Valganciclovir—SLC15A1—SLC-mediated transmembrane transport—ALB—epilepsy syndrome	0.00014	0.000553	CbGpPWpGaD
Valganciclovir—Nausea—Diazepam—epilepsy syndrome	0.00014	0.000187	CcSEcCtD
Valganciclovir—Headache—Zonisamide—epilepsy syndrome	0.00014	0.000187	CcSEcCtD
Valganciclovir—Dyspnoea—Valproic Acid—epilepsy syndrome	0.00014	0.000187	CcSEcCtD
Valganciclovir—Diarrhoea—Carbamazepine—epilepsy syndrome	0.000139	0.000187	CcSEcCtD
Valganciclovir—Angiopathy—Topiramate—epilepsy syndrome	0.000139	0.000187	CcSEcCtD
Valganciclovir—Pruritus—Lamotrigine—epilepsy syndrome	0.000139	0.000187	CcSEcCtD
Valganciclovir—Somnolence—Valproic Acid—epilepsy syndrome	0.000139	0.000187	CcSEcCtD
Valganciclovir—Immune system disorder—Topiramate—epilepsy syndrome	0.000139	0.000186	CcSEcCtD
Valganciclovir—Nervous system disorder—Pregabalin—epilepsy syndrome	0.000139	0.000186	CcSEcCtD
Valganciclovir—Cough—Gabapentin—epilepsy syndrome	0.000139	0.000186	CcSEcCtD
Valganciclovir—Thrombocytopenia—Pregabalin—epilepsy syndrome	0.000139	0.000186	CcSEcCtD
Valganciclovir—Mediastinal disorder—Topiramate—epilepsy syndrome	0.000138	0.000186	CcSEcCtD
Valganciclovir—Tachycardia—Pregabalin—epilepsy syndrome	0.000138	0.000185	CcSEcCtD
Valganciclovir—Chills—Topiramate—epilepsy syndrome	0.000138	0.000185	CcSEcCtD
Valganciclovir—Dyspepsia—Valproic Acid—epilepsy syndrome	0.000138	0.000185	CcSEcCtD
Valganciclovir—Convulsion—Gabapentin—epilepsy syndrome	0.000138	0.000185	CcSEcCtD
Valganciclovir—Skin disorder—Pregabalin—epilepsy syndrome	0.000137	0.000184	CcSEcCtD
Valganciclovir—Hypertension—Gabapentin—epilepsy syndrome	0.000137	0.000184	CcSEcCtD
Valganciclovir—Hyperhidrosis—Pregabalin—epilepsy syndrome	0.000137	0.000183	CcSEcCtD
Valganciclovir—Vomiting—Clonazepam—epilepsy syndrome	0.000137	0.000183	CcSEcCtD
Valganciclovir—Decreased appetite—Valproic Acid—epilepsy syndrome	0.000136	0.000182	CcSEcCtD
Valganciclovir—Alopecia—Topiramate—epilepsy syndrome	0.000136	0.000182	CcSEcCtD
Valganciclovir—Vomiting—Phenytoin—epilepsy syndrome	0.000136	0.000182	CcSEcCtD
Valganciclovir—Dermatitis—Clonazepam—epilepsy syndrome	0.000135	0.000181	CcSEcCtD
Valganciclovir—Arthralgia—Gabapentin—epilepsy syndrome	0.000135	0.000181	CcSEcCtD
Valganciclovir—Nausea—Felbamate—epilepsy syndrome	0.000135	0.000181	CcSEcCtD
Valganciclovir—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	0.000135	0.000181	CcSEcCtD
Valganciclovir—Vomiting—Oxcarbazepine—epilepsy syndrome	0.000135	0.000181	CcSEcCtD
Valganciclovir—Fatigue—Valproic Acid—epilepsy syndrome	0.000135	0.000181	CcSEcCtD
Valganciclovir—Anxiety—Gabapentin—epilepsy syndrome	0.000135	0.000181	CcSEcCtD
Valganciclovir—Anorexia—Pregabalin—epilepsy syndrome	0.000135	0.000181	CcSEcCtD
Valganciclovir—Dizziness—Carbamazepine—epilepsy syndrome	0.000135	0.000181	CcSEcCtD
Valganciclovir—Diarrhoea—Lamotrigine—epilepsy syndrome	0.000135	0.000181	CcSEcCtD
Valganciclovir—Headache—Clonazepam—epilepsy syndrome	0.000135	0.00018	CcSEcCtD
Valganciclovir—Mental disorder—Topiramate—epilepsy syndrome	0.000135	0.00018	CcSEcCtD
Valganciclovir—Dermatitis—Phenytoin—epilepsy syndrome	0.000134	0.00018	CcSEcCtD
Valganciclovir—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	0.000134	0.00018	CcSEcCtD
Valganciclovir—Constipation—Valproic Acid—epilepsy syndrome	0.000134	0.000179	CcSEcCtD
Valganciclovir—Pain—Valproic Acid—epilepsy syndrome	0.000134	0.000179	CcSEcCtD
Valganciclovir—Dermatitis—Oxcarbazepine—epilepsy syndrome	0.000134	0.000179	CcSEcCtD
Valganciclovir—Headache—Phenytoin—epilepsy syndrome	0.000134	0.000179	CcSEcCtD
Valganciclovir—Malnutrition—Topiramate—epilepsy syndrome	0.000134	0.000179	CcSEcCtD
Valganciclovir—Discomfort—Gabapentin—epilepsy syndrome	0.000134	0.000179	CcSEcCtD
Valganciclovir—Headache—Oxcarbazepine—epilepsy syndrome	0.000133	0.000178	CcSEcCtD
Valganciclovir—Nausea—Zonisamide—epilepsy syndrome	0.000132	0.000178	CcSEcCtD
Valganciclovir—Dry mouth—Gabapentin—epilepsy syndrome	0.000132	0.000177	CcSEcCtD
Valganciclovir—Hypotension—Pregabalin—epilepsy syndrome	0.000132	0.000177	CcSEcCtD
Valganciclovir—Flatulence—Topiramate—epilepsy syndrome	0.000132	0.000177	CcSEcCtD
Valganciclovir—Tension—Topiramate—epilepsy syndrome	0.000131	0.000176	CcSEcCtD
Valganciclovir—Dysgeusia—Topiramate—epilepsy syndrome	0.000131	0.000176	CcSEcCtD
Valganciclovir—Confusional state—Gabapentin—epilepsy syndrome	0.000131	0.000175	CcSEcCtD
Valganciclovir—Dizziness—Lamotrigine—epilepsy syndrome	0.00013	0.000175	CcSEcCtD
Valganciclovir—Nervousness—Topiramate—epilepsy syndrome	0.00013	0.000174	CcSEcCtD
Valganciclovir—Anaphylactic shock—Gabapentin—epilepsy syndrome	0.00013	0.000174	CcSEcCtD
Valganciclovir—Oedema—Gabapentin—epilepsy syndrome	0.00013	0.000174	CcSEcCtD
Valganciclovir—Vomiting—Carbamazepine—epilepsy syndrome	0.00013	0.000174	CcSEcCtD
Valganciclovir—Back pain—Topiramate—epilepsy syndrome	0.000129	0.000173	CcSEcCtD
Valganciclovir—Feeling abnormal—Valproic Acid—epilepsy syndrome	0.000129	0.000173	CcSEcCtD
Valganciclovir—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	0.000129	0.000173	CcSEcCtD
Valganciclovir—Infection—Gabapentin—epilepsy syndrome	0.000129	0.000173	CcSEcCtD
Valganciclovir—Muscle spasms—Topiramate—epilepsy syndrome	0.000129	0.000172	CcSEcCtD
Valganciclovir—Dermatitis—Carbamazepine—epilepsy syndrome	0.000128	0.000172	CcSEcCtD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	0.000128	0.000504	CbGpPWpGaD
Valganciclovir—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	0.000128	0.000172	CcSEcCtD
Valganciclovir—Insomnia—Pregabalin—epilepsy syndrome	0.000128	0.000172	CcSEcCtD
Valganciclovir—Nausea—Clonazepam—epilepsy syndrome	0.000128	0.000171	CcSEcCtD
Valganciclovir—Headache—Carbamazepine—epilepsy syndrome	0.000128	0.000171	CcSEcCtD
Valganciclovir—Nervous system disorder—Gabapentin—epilepsy syndrome	0.000127	0.000171	CcSEcCtD
Valganciclovir—Paraesthesia—Pregabalin—epilepsy syndrome	0.000127	0.00017	CcSEcCtD
Valganciclovir—Thrombocytopenia—Gabapentin—epilepsy syndrome	0.000127	0.00017	CcSEcCtD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—AVP—epilepsy syndrome	0.000127	0.0005	CbGpPWpGaD
Valganciclovir—Nausea—Phenytoin—epilepsy syndrome	0.000127	0.00017	CcSEcCtD
Valganciclovir—Tachycardia—Gabapentin—epilepsy syndrome	0.000127	0.00017	CcSEcCtD
Valganciclovir—Dyspnoea—Pregabalin—epilepsy syndrome	0.000126	0.000169	CcSEcCtD
Valganciclovir—Nausea—Oxcarbazepine—epilepsy syndrome	0.000126	0.000169	CcSEcCtD
Valganciclovir—Vision blurred—Topiramate—epilepsy syndrome	0.000126	0.000169	CcSEcCtD
Valganciclovir—Skin disorder—Gabapentin—epilepsy syndrome	0.000126	0.000169	CcSEcCtD
Valganciclovir—Somnolence—Pregabalin—epilepsy syndrome	0.000126	0.000169	CcSEcCtD
Valganciclovir—Hyperhidrosis—Gabapentin—epilepsy syndrome	0.000125	0.000168	CcSEcCtD
Valganciclovir—Tremor—Topiramate—epilepsy syndrome	0.000125	0.000168	CcSEcCtD
Valganciclovir—Vomiting—Lamotrigine—epilepsy syndrome	0.000125	0.000168	CcSEcCtD
Valganciclovir—Urticaria—Valproic Acid—epilepsy syndrome	0.000124	0.000167	CcSEcCtD
Valganciclovir—Ill-defined disorder—Topiramate—epilepsy syndrome	0.000124	0.000166	CcSEcCtD
Valganciclovir—Dermatitis—Lamotrigine—epilepsy syndrome	0.000124	0.000166	CcSEcCtD
Valganciclovir—Body temperature increased—Valproic Acid—epilepsy syndrome	0.000124	0.000166	CcSEcCtD
Valganciclovir—Abdominal pain—Valproic Acid—epilepsy syndrome	0.000124	0.000166	CcSEcCtD
Valganciclovir—Anorexia—Gabapentin—epilepsy syndrome	0.000124	0.000166	CcSEcCtD
Valganciclovir—Anaemia—Topiramate—epilepsy syndrome	0.000124	0.000166	CcSEcCtD
Valganciclovir—Headache—Lamotrigine—epilepsy syndrome	0.000123	0.000165	CcSEcCtD
Valganciclovir—Decreased appetite—Pregabalin—epilepsy syndrome	0.000123	0.000165	CcSEcCtD
Valganciclovir—Agitation—Topiramate—epilepsy syndrome	0.000123	0.000165	CcSEcCtD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	0.000123	0.000484	CbGpPWpGaD
Valganciclovir—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	0.000122	0.000164	CcSEcCtD
Valganciclovir—Fatigue—Pregabalin—epilepsy syndrome	0.000122	0.000164	CcSEcCtD
Valganciclovir—Hypotension—Gabapentin—epilepsy syndrome	0.000121	0.000163	CcSEcCtD
Valganciclovir—Nausea—Carbamazepine—epilepsy syndrome	0.000121	0.000162	CcSEcCtD
Valganciclovir—Pain—Pregabalin—epilepsy syndrome	0.000121	0.000162	CcSEcCtD
Valganciclovir—Constipation—Pregabalin—epilepsy syndrome	0.000121	0.000162	CcSEcCtD
Valganciclovir—Malaise—Topiramate—epilepsy syndrome	0.000121	0.000162	CcSEcCtD
Valganciclovir—Vertigo—Topiramate—epilepsy syndrome	0.00012	0.000161	CcSEcCtD
Valganciclovir—Leukopenia—Topiramate—epilepsy syndrome	0.00012	0.00016	CcSEcCtD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	0.000119	0.000468	CbGpPWpGaD
Valganciclovir—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	0.000118	0.000158	CcSEcCtD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—AVP—epilepsy syndrome	0.000118	0.000464	CbGpPWpGaD
Valganciclovir—Insomnia—Gabapentin—epilepsy syndrome	0.000117	0.000157	CcSEcCtD
Valganciclovir—Nausea—Lamotrigine—epilepsy syndrome	0.000117	0.000157	CcSEcCtD
Valganciclovir—Cough—Topiramate—epilepsy syndrome	0.000117	0.000156	CcSEcCtD
Valganciclovir—Feeling abnormal—Pregabalin—epilepsy syndrome	0.000117	0.000156	CcSEcCtD
Valganciclovir—Paraesthesia—Gabapentin—epilepsy syndrome	0.000117	0.000156	CcSEcCtD
Valganciclovir—Convulsion—Topiramate—epilepsy syndrome	0.000116	0.000155	CcSEcCtD
Valganciclovir—Gastrointestinal pain—Pregabalin—epilepsy syndrome	0.000116	0.000155	CcSEcCtD
Valganciclovir—Dyspnoea—Gabapentin—epilepsy syndrome	0.000116	0.000155	CcSEcCtD
Valganciclovir—Hypertension—Topiramate—epilepsy syndrome	0.000115	0.000155	CcSEcCtD
Valganciclovir—Somnolence—Gabapentin—epilepsy syndrome	0.000115	0.000155	CcSEcCtD
Valganciclovir—Hypersensitivity—Valproic Acid—epilepsy syndrome	0.000115	0.000155	CcSEcCtD
Valganciclovir—Dyspepsia—Gabapentin—epilepsy syndrome	0.000114	0.000153	CcSEcCtD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	0.000114	0.000449	CbGpPWpGaD
Valganciclovir—Arthralgia—Topiramate—epilepsy syndrome	0.000114	0.000153	CcSEcCtD
Valganciclovir—Anxiety—Topiramate—epilepsy syndrome	0.000113	0.000152	CcSEcCtD
Valganciclovir—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	0.000113	0.000152	CcSEcCtD
Valganciclovir—Decreased appetite—Gabapentin—epilepsy syndrome	0.000113	0.000151	CcSEcCtD
Valganciclovir—Discomfort—Topiramate—epilepsy syndrome	0.000113	0.000151	CcSEcCtD
Valganciclovir—Urticaria—Pregabalin—epilepsy syndrome	0.000112	0.000151	CcSEcCtD
Valganciclovir—Asthenia—Valproic Acid—epilepsy syndrome	0.000112	0.000151	CcSEcCtD
Valganciclovir—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	0.000112	0.00015	CcSEcCtD
Valganciclovir—Fatigue—Gabapentin—epilepsy syndrome	0.000112	0.00015	CcSEcCtD
Valganciclovir—Abdominal pain—Pregabalin—epilepsy syndrome	0.000112	0.00015	CcSEcCtD
Valganciclovir—Body temperature increased—Pregabalin—epilepsy syndrome	0.000112	0.00015	CcSEcCtD
Valganciclovir—Dry mouth—Topiramate—epilepsy syndrome	0.000111	0.000149	CcSEcCtD
Valganciclovir—Pain—Gabapentin—epilepsy syndrome	0.000111	0.000149	CcSEcCtD
Valganciclovir—Constipation—Gabapentin—epilepsy syndrome	0.000111	0.000149	CcSEcCtD
Valganciclovir—Pruritus—Valproic Acid—epilepsy syndrome	0.000111	0.000148	CcSEcCtD
Valganciclovir—Confusional state—Topiramate—epilepsy syndrome	0.00011	0.000148	CcSEcCtD
Valganciclovir—Oedema—Topiramate—epilepsy syndrome	0.000109	0.000146	CcSEcCtD
Valganciclovir—Infection—Topiramate—epilepsy syndrome	0.000108	0.000145	CcSEcCtD
Valganciclovir—Diarrhoea—Valproic Acid—epilepsy syndrome	0.000107	0.000144	CcSEcCtD
Valganciclovir—Nervous system disorder—Topiramate—epilepsy syndrome	0.000107	0.000143	CcSEcCtD
Valganciclovir—Feeling abnormal—Gabapentin—epilepsy syndrome	0.000107	0.000143	CcSEcCtD
Valganciclovir—Thrombocytopenia—Topiramate—epilepsy syndrome	0.000107	0.000143	CcSEcCtD
Valganciclovir—Tachycardia—Topiramate—epilepsy syndrome	0.000107	0.000143	CcSEcCtD
Valganciclovir—Gastrointestinal pain—Gabapentin—epilepsy syndrome	0.000106	0.000142	CcSEcCtD
Valganciclovir—Skin disorder—Topiramate—epilepsy syndrome	0.000106	0.000142	CcSEcCtD
Valganciclovir—Hyperhidrosis—Topiramate—epilepsy syndrome	0.000106	0.000141	CcSEcCtD
Valganciclovir—Hypersensitivity—Pregabalin—epilepsy syndrome	0.000104	0.00014	CcSEcCtD
Valganciclovir—Anorexia—Topiramate—epilepsy syndrome	0.000104	0.000139	CcSEcCtD
Valganciclovir—Dizziness—Valproic Acid—epilepsy syndrome	0.000103	0.000139	CcSEcCtD
Valganciclovir—Urticaria—Gabapentin—epilepsy syndrome	0.000103	0.000138	CcSEcCtD
Valganciclovir—Abdominal pain—Gabapentin—epilepsy syndrome	0.000103	0.000137	CcSEcCtD
Valganciclovir—Body temperature increased—Gabapentin—epilepsy syndrome	0.000103	0.000137	CcSEcCtD
Valganciclovir—Hypotension—Topiramate—epilepsy syndrome	0.000102	0.000137	CcSEcCtD
Valganciclovir—Asthenia—Pregabalin—epilepsy syndrome	0.000102	0.000136	CcSEcCtD
Valganciclovir—Pruritus—Pregabalin—epilepsy syndrome	0.0001	0.000134	CcSEcCtD
Valganciclovir—Vomiting—Valproic Acid—epilepsy syndrome	9.95e-05	0.000133	CcSEcCtD
Valganciclovir—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	9.95e-05	0.000133	CcSEcCtD
Valganciclovir—Insomnia—Topiramate—epilepsy syndrome	9.87e-05	0.000132	CcSEcCtD
Valganciclovir—Dermatitis—Valproic Acid—epilepsy syndrome	9.86e-05	0.000132	CcSEcCtD
Valganciclovir—Headache—Valproic Acid—epilepsy syndrome	9.8e-05	0.000131	CcSEcCtD
Valganciclovir—Paraesthesia—Topiramate—epilepsy syndrome	9.8e-05	0.000131	CcSEcCtD
Valganciclovir—Dyspnoea—Topiramate—epilepsy syndrome	9.73e-05	0.00013	CcSEcCtD
Valganciclovir—Somnolence—Topiramate—epilepsy syndrome	9.7e-05	0.00013	CcSEcCtD
Valganciclovir—Diarrhoea—Pregabalin—epilepsy syndrome	9.68e-05	0.00013	CcSEcCtD
Valganciclovir—Dyspepsia—Topiramate—epilepsy syndrome	9.61e-05	0.000129	CcSEcCtD
Valganciclovir—Hypersensitivity—Gabapentin—epilepsy syndrome	9.56e-05	0.000128	CcSEcCtD
Valganciclovir—Decreased appetite—Topiramate—epilepsy syndrome	9.49e-05	0.000127	CcSEcCtD
Valganciclovir—Gastrointestinal disorder—Topiramate—epilepsy syndrome	9.42e-05	0.000126	CcSEcCtD
Valganciclovir—Fatigue—Topiramate—epilepsy syndrome	9.41e-05	0.000126	CcSEcCtD
Valganciclovir—Dizziness—Pregabalin—epilepsy syndrome	9.36e-05	0.000125	CcSEcCtD
Valganciclovir—Constipation—Topiramate—epilepsy syndrome	9.33e-05	0.000125	CcSEcCtD
Valganciclovir—Pain—Topiramate—epilepsy syndrome	9.33e-05	0.000125	CcSEcCtD
Valganciclovir—Asthenia—Gabapentin—epilepsy syndrome	9.31e-05	0.000125	CcSEcCtD
Valganciclovir—Nausea—Valproic Acid—epilepsy syndrome	9.3e-05	0.000125	CcSEcCtD
Valganciclovir—Pruritus—Gabapentin—epilepsy syndrome	9.18e-05	0.000123	CcSEcCtD
Valganciclovir—Vomiting—Pregabalin—epilepsy syndrome	9e-05	0.000121	CcSEcCtD
Valganciclovir—Feeling abnormal—Topiramate—epilepsy syndrome	9e-05	0.000121	CcSEcCtD
Valganciclovir—Gastrointestinal pain—Topiramate—epilepsy syndrome	8.93e-05	0.00012	CcSEcCtD
Valganciclovir—Dermatitis—Pregabalin—epilepsy syndrome	8.91e-05	0.000119	CcSEcCtD
Valganciclovir—Diarrhoea—Gabapentin—epilepsy syndrome	8.88e-05	0.000119	CcSEcCtD
Valganciclovir—Headache—Pregabalin—epilepsy syndrome	8.86e-05	0.000119	CcSEcCtD
Valganciclovir—Urticaria—Topiramate—epilepsy syndrome	8.67e-05	0.000116	CcSEcCtD
Valganciclovir—Abdominal pain—Topiramate—epilepsy syndrome	8.63e-05	0.000116	CcSEcCtD
Valganciclovir—Body temperature increased—Topiramate—epilepsy syndrome	8.63e-05	0.000116	CcSEcCtD
Valganciclovir—Dizziness—Gabapentin—epilepsy syndrome	8.58e-05	0.000115	CcSEcCtD
Valganciclovir—Nausea—Pregabalin—epilepsy syndrome	8.4e-05	0.000113	CcSEcCtD
Valganciclovir—Vomiting—Gabapentin—epilepsy syndrome	8.25e-05	0.000111	CcSEcCtD
Valganciclovir—Dermatitis—Gabapentin—epilepsy syndrome	8.17e-05	0.00011	CcSEcCtD
Valganciclovir—Headache—Gabapentin—epilepsy syndrome	8.13e-05	0.000109	CcSEcCtD
Valganciclovir—Hypersensitivity—Topiramate—epilepsy syndrome	8.04e-05	0.000108	CcSEcCtD
Valganciclovir—Asthenia—Topiramate—epilepsy syndrome	7.83e-05	0.000105	CcSEcCtD
Valganciclovir—Pruritus—Topiramate—epilepsy syndrome	7.72e-05	0.000104	CcSEcCtD
Valganciclovir—Nausea—Gabapentin—epilepsy syndrome	7.71e-05	0.000103	CcSEcCtD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—ALB—epilepsy syndrome	7.69e-05	0.000303	CbGpPWpGaD
Valganciclovir—Diarrhoea—Topiramate—epilepsy syndrome	7.47e-05	0.0001	CcSEcCtD
Valganciclovir—Dizziness—Topiramate—epilepsy syndrome	7.22e-05	9.68e-05	CcSEcCtD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	7.13e-05	0.000281	CbGpPWpGaD
Valganciclovir—Vomiting—Topiramate—epilepsy syndrome	6.94e-05	9.3e-05	CcSEcCtD
Valganciclovir—Dermatitis—Topiramate—epilepsy syndrome	6.88e-05	9.22e-05	CcSEcCtD
Valganciclovir—Headache—Topiramate—epilepsy syndrome	6.84e-05	9.17e-05	CcSEcCtD
Valganciclovir—Nausea—Topiramate—epilepsy syndrome	6.48e-05	8.69e-05	CcSEcCtD
